RnR Market Research

CINV Industry Growth Drivers and Forecasts Analysis 2020 Now Available at MarketReportsOnline

MarketReportsOnline.com adds Global Chemotherapy Induced Nausea & Vomiting (CINV) Market: Size, Trends & Forecasts (2016-2020) research report of 68 pages on the Chemotherapy Induced Nausea & Vomiting industry to the pharmaceuticals intelligence collection of its research store.


Pune, India -- (SBWIRE) -- 06/09/2017 -- The report titled "Global Chemotherapy Induced Nausea & Vomiting (CINV) Market: Size, Trends & Forecasts (2016-2020)", provides and in-depth analysis of the global CINV market and respective drugs. The report gives an insight of the global CINV market by 5-HT3 and NK-1 drug receptor antagonists.

Complete report on Chemotherapy Induced Nausea & Vomiting (CINV) Market spread across 68 pages providing 4 company profiles and 5 tables and 37 figures is now available at http://www.marketreportsonline.com/502661.html.

The report also includes the analysis of North American CINV market. The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global CINV market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The key players of the global CINV market, Heron Therapeutics, Inc., Merck & Co., Inc., Novartis AG and TESARO, Inc. are also profiled with their financial information and respective business strategies

Chemotherapy induced nausea and vomiting (CINV) is the most dreaded side-effect of chemotherapy among the cancer patients. Therefore, sometimes patients either do not undergo the chemotherapy or discontinue in the prior year of treatment. CINV is also of various types such as acute, breakthrough, delayed, anticipatory and refractory. HEC and MEC regimens cause the CINV. Several treatments of CINV are on the verge of emergence such as 5-HT3 receptor antagonist, NK-1 blocker, corticosteroids, cannabinoids and dopamine antagonists. However, there are several unmet medical needs in the field of HEC regimen of delayed CINV.

Purchase a copy of this "Global Chemotherapy Induced Nausea & Vomiting (CINV) Market: Size, Trends & Forecasts (2016-2020)" research report at http://www.marketreportsonline.com/contacts/purchase.php?name=502661.

Major Points from Table of Contents:

1. Executive Summary

2. Introduction
2.1 Chemotherapy: An Overview
2.2 CINV: An Overview

3. Global Market Analysis
3.1 Global CINV Market: An Analysis
3.2 Global NK-1 Drug Receptor Antagonist Market
3.3 Global 5-HT3 Drug Receptor Antagonist Market

4. Regional Market Analysis
4.1 North America CINV Market: An Analysis

5. Market Dynamics
5.1 Growth Driver
5.2 Challenges
5.3 Market Trends

6. Competitive Landscape
6.1 CINV Market Players by Agents Approved and In Development
6.2 Global CINV Product : NK1 Receptor Antagonists

7. Company Profile

Browse all latest reports on pharmaceuticals market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html.

About MarketReportsOnline
MarketReportsOnline comprises of an online library of 2,50,000 reports and in-depth market research studies of over 5000+ micro markets. We provide 24/7 online and offline support to our customers. Get in touch with us for your needs of market research reports.

Contact Us:
Ritesh Tiwari
2nd Floor, Metropole,
Next to Inox Theatre,
Bund Garden Road,
Pune - 411001.
Maharashtra, India.
Tel: 888-391-5441
E-mail: sales@marketreportsonline.com